Raymond James Financial
IRWD icon

Raymond James Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Raymond James Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.68M Sell
763,955
-105,871
-12% -$434K ﹤0.01% 3111
2025
Q4 		$2.93M Buy
869,826
+854,780
+5,681% +$2.22M ﹤0.01% 2946
2025
Q3 		$19.7K Sell
15,046
-249
-2% -$258 ﹤0.01% 4906
2025
Q2 		$11K Hold
15,295
– – ﹤0.01% 5889
2025
Q1 		$22.5K Hold
15,295
– – ﹤0.01% 4708
2024
Q4 		$67.8K Buy
+15,295
New +$62.1K ﹤0.01% 4569

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Raymond James Financial's IRWD Position: Q1 2026 in Review

Raymond James Financial reduced its Ironwood Pharmaceuticals (IRWD) stake by 12% in Q1 2026, selling an estimated $434K and leaving 763,955 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3111.

Raymond James Financial first reported a position in IRWD in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.93M in Q4 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Raymond James Financial held 763,955 shares of Ironwood Pharmaceuticals worth $2.68M as of Q1 2026.
  • Raymond James Financial sold 105,871 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $434K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3111 holding.
  • Raymond James Financial first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Ironwood Pharmaceuticals position peaked at $2.93M in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.